Lemaitre Vascular (LMAT) Accumulated Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Accumulated Expenses data on file, last reported at $10.3 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 7.75% year-over-year to $10.3 million in Q1 2026; TTM through Mar 2026 was $10.3 million, a 7.75% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 1811.11% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $10.3 million, up from $2.8 million in the prior quarter.
• Over the last five years, Accumulated Expenses for LMAT reached as high as $26.9 million in Q3 2025 and fell as low as $144000.0 in Q4 2024.
• Historically, Accumulated Expenses has averaged $9.1 million across 5 years, with a median of $9.5 million in 2025.
• Across the five-year window, Accumulated Expenses slumped 98.92% in 2024 and surged 1811.11% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $3.7 million in 2022, then jumped by 256.27% to $13.4 million in 2023, then slumped by 98.92% to $144000.0 in 2024, then jumped by 1811.11% to $2.8 million in 2025, then soared by 273.8% to $10.3 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $10.3 million in Q1 2026, $2.8 million in Q4 2025, and $26.9 million in Q3 2025.